Eli Lilly and Company (LLY) News Today → CEO of Biggest AI Chipmaker Just Dropped a Bombshell… (From Banyan Hill Publishing) (Ad) Free LLY Stock Alerts $770.00 -1.12 (-0.15%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 18 at 7:05 AM | marketbeat.comEli Lilly and Company Q1 Earnings TranscriptMay 18 at 12:39 AM | marketbeat.comFiera Capital Corp Sells 1,635 Shares of Eli Lilly and Company (NYSE:LLY)Fiera Capital Corp lowered its stake in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 10.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 13,316 shares of the company's stock after selling 1,635 shares duMay 17 at 3:02 PM | investorplace.comPharma Stocks Outlook: Where Are 2024's Top Performers Headed Next?May 17 at 2:49 PM | marketbeat.comEli Lilly and Company (NYSE:LLY) Stock Price Up 0.1%Eli Lilly and Company (NYSE:LLY) Stock Price Up 0.1%May 17 at 2:44 PM | investorplace.comRally Rockets: 3 Stocks Benefitting From the Market's Unstoppable SurgeMay 17 at 8:55 AM | msn.comEli Lilly says its experimental weekly insulin works just as well as daily dosesMay 17 at 12:21 AM | marketbeat.comHaverford Trust Co Sells 1,445 Shares of Eli Lilly and Company (NYSE:LLY)Haverford Trust Co trimmed its stake in Eli Lilly and Company (NYSE:LLY - Free Report) by 23.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,834 shares of the company's stock after selling 1,445 shares dMay 16 at 5:36 PM | marketbeat.comEli Lilly and Company (NYSE:LLY) Stock Price Down 1.4%Eli Lilly and Company (NYSE:LLY) Trading Down 1.4%May 16 at 10:41 AM | msn.comEli Lilly once-weekly insulin hits main goal in late-stage trialsMay 16 at 10:41 AM | finance.yahoo.comRoche’s New Weight-Loss Data Shows Lilly Isn’t Unbeatable in ObesityMay 16 at 9:17 AM | investorplace.comThe Dividend Investor’s Playbook: 3 Stocks for Consistent Cash Flow in 2024May 16 at 8:13 AM | investorplace.comThe Dividend Investor's Playbook: 3 Stocks for Consistent Cash Flow in 2024May 16 at 8:00 AM | globenewswire.comTotus Medicines Announces Strategic Multi-Target Research Collaboration with LillyMay 16 at 7:15 AM | investorplace.com7 Pharma Stocks Harnessing AI Brainpower for Big BreakthroughsMay 16 at 7:15 AM | fool.comThese 2 No-Brainer Growth Stocks Are Breaking New GroundMay 16 at 6:56 AM | reuters.comLilly's weekly insulin succeeds in late-stage studiesMay 16 at 6:45 AM | prnewswire.comWith Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily InsulinMay 16 at 3:40 AM | americanbankingnews.comEli Lilly and Company (NYSE:LLY) PT Raised to $840.00 at ArgusMay 16 at 1:38 AM | americanbankingnews.comEli Lilly and Company (NYSE:LLY) Trading Up 2% After Analyst UpgradeMay 15 at 11:24 PM | marketwatch.comEli Lilly Ethics/Compliance Chief Alonzo Weems to RetireMay 15 at 11:24 PM | msn.comA pill could solve the Zepbound and Wegovy shortage, Eli Lilly executive saysMay 15 at 11:24 PM | nasdaq.comHow Are Eli Lilly's Profit Margins Trending?May 15 at 10:04 PM | marketbeat.comEli Lilly and Company (NYSE:LLY) Shares Sold by Janney Montgomery Scott LLCJanney Montgomery Scott LLC lowered its stake in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 3.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 264,349 shares of the company's stock after selling 10,328May 15 at 6:23 PM | forbes.comHow Are Eli Lilly’s Profit Margins Trending?May 15 at 1:09 PM | investorplace.comWall Street Favorites: 3 Growth Stocks With Strong Buy Ratings for May 2024May 15 at 11:27 AM | marketbeat.comEli Lilly and Company (NYSE:LLY) Trading 2% Higher on Analyst UpgradeEli Lilly and Company (NYSE:LLY) Trading 2% Higher After Analyst UpgradeMay 15 at 8:49 AM | finance.yahoo.comEli Lilly’s and AstraZeneca’s Former Head of Research Dr. Jan Lundberg Elected as a New Board MemberMay 15 at 8:49 AM | msn.comHow to solve the weight loss drug shortage, according to a top Eli Lilly executiveMay 15 at 8:00 AM | prnewswire.comAlonzo Weems to Retire as Executive Vice President of Enterprise Risk Management and Chief Ethics and Compliance OfficerMay 15 at 5:44 AM | fool.comThese 2 Words Explain Why Eli Lilly Stock Is a Buy Right NowMay 15 at 12:33 AM | marketbeat.comCampbell Wealth Management Buys 1,724 Shares of Eli Lilly and Company (NYSE:LLY)Campbell Wealth Management grew its stake in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 209.5% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,547 shares of the company's stock after acquiring an additional 1,724 sharesMay 14, 2024 | reuters.comEli Lilly reaches settlement with spa selling Mounjaro, Zepbound knockoffsMay 14, 2024 | finance.yahoo.comLilly Settles With Spa Selling Mounjaro, Zepbound Knock-OffsMay 14, 2024 | marketbeat.comEli Lilly and Company (NYSE:LLY) Shares Down 0.6% Eli Lilly and Company (NYSE:LLY) Stock Price Down 0.6%May 14, 2024 | marketbeat.comArgus Boosts Eli Lilly and Company (NYSE:LLY) Price Target to $840.00Argus increased their price objective on Eli Lilly and Company from $770.00 to $840.00 and gave the company a "buy" rating in a report on Tuesday.May 14, 2024 | fool.com2 Top Pharma Stocks That Just Keep Getting Better and BetterMay 14, 2024 | fool.comIs Eli Lilly's Latest Deal a Gamechanger?May 14, 2024 | fool.com3 Magnificent Stocks That Are Passive Income MachinesMay 13, 2024 | marketbeat.comAlmanack Investment Partners LLC. Sells 1,544 Shares of Eli Lilly and Company (NYSE:LLY)Almanack Investment Partners LLC. lowered its position in Eli Lilly and Company (NYSE:LLY - Free Report) by 63.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 891 shares of the company'May 13, 2024 | marketbeat.comEli Lilly and Company (NYSE:LLY) Stock Price Down 1.2%Eli Lilly and Company (NYSE:LLY) Trading Down 1.2%May 13, 2024 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Eli Lilly & Co (LLY), TruBridge (TBRG) and Ligand Pharma (LGND)May 13, 2024 | forbes.comIs Eli Lilly Stock A Better Pick Over Amgen?May 13, 2024 | investorplace.comThe Must-Watch List: 3 Stocks to Snap Up as Soon as They Hit Bargain TerritoryMay 12, 2024 | marketbeat.comEli Lilly and Company (NYSE:LLY) Shares Bought by Advisor OS LLCAdvisor OS LLC raised its holdings in Eli Lilly and Company (NYSE:LLY - Free Report) by 51.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,039 shares of the company's stock after acquiring an additional 1,377 shares durMay 12, 2024 | americanbankingnews.comEli Lilly and Company (NYSE:LLY) Stock Price Down 0.7%May 11, 2024 | marketbeat.comDimensional Fund Advisors LP Boosts Stake in Eli Lilly and Company (NYSE:LLY)Dimensional Fund Advisors LP increased its position in Eli Lilly and Company (NYSE:LLY - Free Report) by 0.8% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 3,395,896 shares of the company's stock after buying an additional 28,104 shares during the period.May 11, 2024 | fool.com1 No-Brainer Growth Stock to Buy and HoldMay 11, 2024 | marketbeat.comMarketBeat Week in Review – 5/6 - 5/10 (LLY)Sell in May, then go away got pushed to the side this week, but the bearish sentiment could return when investors get the latest read on inflation next week.May 11, 2024 | fool.comWant Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.May 11, 2024 | reuters.comIndia's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says Get Eli Lilly and Company News Delivered to You Automatically Sign up to receive the latest news and ratings for LLY and its competitors with MarketBeat's FREE daily newsletter. Email Address Shocking $16T Elon Musk Crypto Leak (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. Related VideosBiotech Boom: Stocks Skyrocketing & What's Next LLY Media Mentions By Week LLY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LLY News Sentiment▼0.500.51▲Average Medical News Sentiment LLY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LLY Articles This Week▼5034▲LLY Articles Average Week Get Eli Lilly and Company News Delivered to You Automatically Sign up to receive the latest news and ratings for LLY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Johnson & Johnson News Today Merck & Co., Inc. News Today AbbVie News Today Novo Nordisk A/S News Today AstraZeneca News Today Novartis News Today UnitedHealth Group News Today Thermo Fisher Scientific News Today Pfizer News Today Bristol-Myers Squibb News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:LLY) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & CompanyCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaMissed NVDA? Buy this AI stock NOWChaikin AnalyticsMost important medical advance in 100 yearsThe Oxford ClubThe Presidential candidate you should REALLY be worried aboutStansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eli Lilly and Company Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
